XML 16 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
Preferred Stock [Member]
Additional Paid in Capital, Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid in Capital, Common Stock [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2017   2,651,952      
Balance at Dec. 31, 2017 $ 477,342 $ 71,887,674 $ (65,426,329) $ 6,938,687
Issuance of Series B convertible preferred stock and warrants, net of issuance costs of $1,333,449 (in shares) 13,624        
Issuance of Series B convertible preferred stock and warrants, net of issuance costs of $1,333,449 $ 14 6,926,778 5,363,759 12,290,551
Allocation of Series B convertible preferred stock proceeds to beneficial conversion feature (4,782,100) 4,782,100
Deemed Dividend on Series B convertible preferred stock 11,479,308 (11,479,308)
Conversion of Series B convertible preferred stock to common stock (in shares) (10,107)   2,871,303      
Conversion of Series B convertible preferred stock to common stock $ (10) (10,106,990) $ 516,833 9,590,167
Amortization of commitment shares (59,556) (59,556)
Compensation cost for stock options granted to executives and employees 726,252 726,252
Net loss (9,326,825) (9,326,825)
Balance (in shares) at Sep. 30, 2018 3,517   5,523,255      
Balance at Sep. 30, 2018 $ 4 $ 3,516,996 $ 994,175 $ 80,811,088 $ (74,753,154) $ 10,569,109